Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides

B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics

Diffuse idiopathic skeletal hyperostosis associated ossification of the posterior longitudinal ligament

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat

The crossbow sign in extracranial giant cell arteritis

[Which taxonomy for inflammatory diseases in rheumatology? The concept of Psout]

Single tumor-like tophus

Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency

Diagnostic uncertainty and clinical decision-making strategies

Homozygosity for the V377I mutation in mevalonate kinase causes distinct clinical phenotypes in two sibs with hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS)

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency

Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study

Fibrous nodules over the patella revealing acrodermatitis chronica atrophicans

[Still disease with heterozygous MEFV mutation]

Gemcitabine-induced myopathy

Acute hepatitis E during biotherapy

Second reported case of human infection with Streptococcus equi subsp. ruminatorum

[Inaugural bilateral panuveitis in relapsing polychondritis]

Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes

BAFF synthesis by rheumatoid synoviocytes is positively controlled by alpha5beta1 integrin stimulation and is negatively regulated by tumor necrosis factor alpha and Toll-like receptor ligands

Response to: 'Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab' by Messina et al

Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept

Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2-5 and MAXIMISE studies

Response to: 'Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab' by Messina et al

In antisynthetase syndrome, ACPA are associated with severe and erosive arthritis: an overlapping rheumatoid arthritis and antisynthetase syndrome

Temporomandibular joint dysfunction and selected health parameters in the elderly

At the crossroads of gout and psoriatic arthritis: "psout"

Improving patient pathways for systemic lupus erythematosus: a multistakeholder pathway optimisation study

Efficacy of Continuous Interleukin 1 Blockade in Mevalonate Kinase Deficiency: A Multicenter Retrospective Study in 13 Adult Patients and Literature Review

Enthesitis of the ligamentum teres femoris in axial spondyloarthritis